While many plans dont cover GLP-1 drugs for weight loss alone, they may make exceptions if you have other conditions
Duration: 64-week treatment + 7-week follow-up (71 weeks total) Enrollment: 307 patients Randomization: 2:1 Dose escalation: 3 7 14 mg, reaching 25 mg maintenance at week 12 ATTAIN-1 Trial A large-scale trial evaluating multiple dose levels of the small molecule Orforglipron
adding less does the opposite
BioSpace regrets the error.
The abdomen is the most popular site, roughly two inches out from the navel, though the thigh and the back of the upper arm work well too
However, downstream effects such as body composition changes, improved sleep quality, or visceral fat reduction typically require consistent administration over several weeks to months of research